News

GLASGOW, SCOTLAND--(Marketwired - Oct 9, 2017) - HCi Viocare ("the Company" ( OTCQB : VICA )) is delighted to welcome Dr. John Doupis, MD, PhD to its team. Dr. Doupis joins the Scientific Advisory Board assuming the role of Director of Clinical Matters and Diabetes. Dr. Doupis is a former Clinical Research Fellow of the Joslin Diabetes Center,... more
GLASGOW, SCOTLAND - HCi Viocare (OTCQB: VICA) is pleased to announce that it has shipped the world’s 1 st Smart Diabetic Walker Boot, equipped with the company’s patent pending Flexisense technology, to a global diabetes-market leading manufacturer. The Flexisense smart diabetic walker allows the user or the clinician to identify high pressure or... more
We are please do annouce that effective July 19, 2017, HCi Viocare Clinics UK Limited ( a wholly owned subsidiary of the Company) and Tharawat Holdings Company ("Tharawat"), a company incorporated under the laws of Saudi Arabia, entered into a Joint Venture agreement for the formation of a company in the Kingdom of Saudi Arabia, with the purpose... more
In April 2017 HCI Viocare's wholly owned UK based subsidiary, HCI Viocare Technologies Ltd. participated in a prestigious and collaborative research grant proposal along with the Imperial College of London and Ossur Inc. (the no. 2 manufacturer of prosthetic and orthotic devices in the world, with an annual sales of $521 million USD) as well as... more

Pages